Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: A large-scale case-control study

Archives of Gynecology and Obstetrics

Volumn 287, Issue 3, 2013, Pages 525-531

  Zhang, Hong Yuan ^a   Guo, Cheng Xiu ^a   Zhu, Fu Fan ^b   Qu, Peng Peng ^a   Lin, Wan Jun ^a   Xiong, Jing ^b  

^a Tianjin Central Gynecology and Obstetrics Hospital   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Chinese women; Diagnostic criteria; Obesity; Phenotype; Polycystic ovary syndrome

Indexed keywords

ESTRADIOL; FOLLITROPIN; INSULIN; LUTEINIZING HORMONE; TESTOSTERONE;

ACNE; ADULT; ARTICLE; BODY MASS; CHINESE; CLINICAL FEATURE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; FEMALE GENITAL TRACT PARAMETERS; FERRIMAN AND GALLWEY SCORE; HIRSUTISM; HUMAN; HYPERANDROGENISM; INSULIN RESISTANCE; LUTEINIZING HORMONE FOLLICLE STIMULATING HORMONE RATIO; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MENSTRUAL IRREGULARITY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OBESITY; OUTCOME ASSESSMENT; OVARIAN FOLLICLE NUMBER; OVARIAN VOLUME; OVARY POLYCYSTIC DISEASE; PHENOTYPE; POPULATION BASED CASE CONTROL STUDY; ROTTERDAM CRITERIA; SCORING SYSTEM; TESTOSTERONE BLOOD LEVEL; TRANSVAGINAL ECHOGRAPHY;

ACNE VULGARIS; ADOLESCENT; ADULT; ANOVULATION; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; CASE-CONTROL STUDIES; CHINA; FEMALE; FOLLICLE STIMULATING HORMONE; HIRSUTISM; HUMANS; HYPERANDROGENISM; INSULIN RESISTANCE; LUTEINIZING HORMONE; MIDDLE AGED; OBESITY; OVARY; POLYCYSTIC OVARY SYNDROME; YOUNG ADULT;

EID: 84878358588     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-012-2568-z     Document Type: Article

References (37)

1. Broekmans FJ, Knauff EA, Valkenburg O et al (2006) PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG 113:1210-1217
2. Hudecova M, Holte J, Olovsson M, Larsson A, Berne C, Poromaa IS (2011) Diabetes and impaired glucose tolerance in patients with polycystic ovary syndrome - a long term follow-up. Hum Reprod 26:1462-1468
3. Bhathena RK (2011) Insulin resistance and the long-term consequences of polycystic ovary syndrome. J Obstet Gynaecol 31:105-110
4. Hacihanefioglu B (2000) Polycystic ovary syndrome nomenclature: chaos? Fertil Steril 73:1261-1262
5. Zhang HY, Zhu FF, Xiong J, Shi XB, Fu SX (2009) Characteristics of different phenotypes of polycystic ovary syndrome based on the rotterdam criteria in a large-scale Chinese population. BJOG 116:1633-1639
6. Zawadski JK, Dunaif A (1992) Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine F (eds) Polycystic ovary syndrome. Blackwell Scientific, Boston, pp 377-384
7. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19-25
8. Marcondes JA, Barcellos CR, Rocha MP (2011) Difficulties and pitfalls in the diagnosis of polycystic ovary syndrome. Arq Bras Endocrinol Metabol 55(1):6-15
9. Azziz R (2005) Diagnostic criteria for polycystic ovarian syndrome: a reappraisal. Fertil Steril 83:1343-1346
10. Chen X, Yang D, Li L, Feng S, Wang L (2006) Abnormal glucose tolerance in Chinese women with polycystic ovary syndrome. Hum Reprod 21:2027-2032
11. Legro RS, Kunselman AR, Dodson WC, Dunaif A (1999) Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84:165-169
12. The Asia-Pacific Perspective (2000) Redefining obesity and its treatment. International Diabetes Institute, Melbourne
13. Ferriman D, Gallwey JD (1961) Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 21:1440-1447
14. Mather KJ, Hunt AE, Sterinberg HO et al (2001) Repeatability characteristics of simple indices of insulin resistance implications for research applications. J Clin Endocrinol Metab 86(11):5457-5464
15. Liou TH, Yang JH, Hsieh CH, Lee CY, Hsu CS, Hsu MI (2008) Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women. Fertil Steril 1:1-6
16. Lin JF, Li X, Zhu MW (2006) Exploration of the classification of polycystic ovarian syndrome. Zhonghua Fu Chan Ke Za Zhi 41:684-688
17. Lam PM, Tam WH, Cheung LP (2008) Higher metabolic risk in Chinese women fulfilling the NIH diagnostic criteria for polycystic ovarian syndrome. Fertil Steril (Epub 11 Oct 2008)
18. Diamanti-Kandarakis E, Panidis D (2007) Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS. Clin Endocrinol 67:735-742
19. Lookingbill DP, Azziz R (1997) Measurement of peripheral androgen action. In: Azziz R, Nestler JE, Dewailly D (eds) Androgen excess disorders in women. Lippincott-Raven, Philadelphia, pp 657-664
20. Li L, Yang D, Chen X, Chen Y, Feng S, Wang L (2007) Clinical and metabolic features of polycystic ovary syndrome. Int J Gynaecol Obstet 97:129-134
21. Diamanti-Kandarakis E, Kouli CR, Bergiele AT et al (1999) A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 84:4006-4011
22. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF (2000) A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 85:2434-2438
23. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R (1998) Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 83:3078-3082
24. Jonard S, Robert Y, Dewailly D (2005) Revisiting the ovarian volume as a diagnostic criterion for polycystic ovaries. Hum Reprod 20:2893-2898
25. Hart R, Hickey M, Franks S (2004) Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 18:671-683
26. Chan CC, Ng EH, Tang OS, Lee CP, Ho PC (2006) The prevalence of polycystic ovaries in Chinese women with a history of gestational diabetes mellitus. Gynecol Endocrinol 22:516-520
27. Hsu MI, Liou TH, Chou SY, Chang CY, Hsu CS (2007) Diagnostic criteria for polycystic ovary syndrome in Taiwanese Chinese women: comparison between Rotterdam 2003 and NIH 1990. Fertil Steril 88:727-729
28. Nestler JE, Clore JN, Blackard WG (1989) The central role of obesity (hyperinsulinemia) in the pathogenesis of the polycystic ovary syndrome. Am J Obstet Gynecol 161:1095-1097
29. Dunaif A, Segal KR, Futterweit W, Dobrjansky A (1989) Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38:1165-1174
30. Zhu YG, Su YH, Zhang YW (1999) Polycystic ovary syndrome. In: Cao ZY (ed) Chinese obstetrics and gynecology, 1st edn. Republic Health Publishing Company, Beijing, pp 2176-2216
31. Legro RS, Castracane VD, Kauffman RP (2004) Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv 59:141-154
32. Toprak S, Yonem A, Cakir B et al (2001) Insulin resistance in nonobese patients with polycystic ovary syndrome. Horm Res 55:65-70
33. Yildiz BO, Gedik O (2004) Assessment of glucose intolerance and insulin sensitivity in polycystic ovarian syndrome. Reprod Biomed 8:649-656
34. Yen SS, Vela P, Rankin J (1970) Inappropriate secretion of follicle-stimulating hormone and luteinizing hormone in polycystic ovarian disease. J Clin Endocrinol Metab 30:435-442
35. Holte J, Bergh T, Gennarelli G, Wide L (1994) The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women. Clin Endocrinol 41:473-481
36. Taylor AE, McCourt B, Martin KA et al (1997) Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab 82:2248-2256
37. Cussons AJ, Stuckey BG, Walsh JP, Burke V, Norman RJ (2005) Polycystic ovarian syndrome: marked differences between endocrinologists and gynecologists in diagnosis and management. Clin Endocrinol 62:289-295